Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada
Saturday, July 23, 2022Ascentage Pharma a global biopharmaceutical company engaged in developing novel therapies for cancers chronic hepatitis B CHB and agerelated diseases today announced that the Phase Ib study of Ascentage Pharmas novel drug candidate olverembatinib HQP...
Artizan Biosciences Announces Multi-Year Research Collaboration with the University Medical Center Utrecht and Microviable Therapeutics SL
Friday, July 22, 2022Artizan Biosciences Inc a biotechnology company creating gut exclusive microbial metalloprotease inhibitors GEMMi a new class of transformative precision therapeutics that disrupt chronic inflammatory disease triggers today announced that it has ente...
Scientific Innovation and Collaboration Highlighted at AIDS 2022 as Gilead Extends Leadership Efforts Toward Ending the Global HIV Epidemic
Friday, July 22, 2022Gilead Sciences Inc announced its upcoming contributions to the th International AIDS Conference AIDS AIDS will be a hybrid conference taking place in person in Montreal Canada as well as virtually from July August As the leader in HIV innovation...
Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug
Thursday, July 21, 2022As many Korean pharmaceutical manufacturers are currently attempting to develop new drugs for idiopathic pulmonary fibrosis Daewoong Pharmaceuticals new medication DWN has been fasttracked by the American FDA the first time a Korean pharma company ha...
Biocytogen and LiberoThera Achieve Milestone Progress in Co-Development of Fully Human GPCR Antibody Drugs
Thursday, July 21, 2022Biocytogen Pharmaceuticals Beijing Co Ltd entered a strategic collaboration with LiberoThera Co Ltd LiberoThera to codevelop fully human GPCR antibodies using Biocytogens advanced antibody discovery platform based on fully human antibody RenMabTM mic...
Gilead Sciences Signs New Joint Procurement Agreement with the European Commission for Veklury® (Remdesivir)
Wednesday, July 20, 2022Gilead Sciences and the European Commission today signed a new joint procurement agreement JPA that will ensure continued rapid and equitable access to Veklury remdesivir for participating Member States across the European Union EU and European Econo...
Sorrento Therapeutics Announces the FDA IND Clearance of STI-1558, An Oral M(pro) and Cathepsin L Inhibitor to Treat COVID-19
Wednesday, July 20, 2022Sorrento Therapeutics Inc announced the FDA clearance of a Phase study of its oral main viral protease Mpro inhibitor STI in patients with impaired renal and hepatic function A previously announced Phase study of STI evaluating single ascending dos...
Nabriva Therapeutics Expands XENLETA® (lefamulin) Presence with Exclusive Agreement with Er-Kim Pharmaceuticals
Tuesday, July 19, 2022Nabriva Therapeutics plc a biopharmaceutical company engaged in the commercialization and development of innovative antiinfective agents to treat serious infections today announced that it has entered into an exclusive Distribution Agreement with ErK...
Azurity Pharmaceuticals, Inc. announces FDA Approval of Zonisade™ (Zonisamide Oral Suspension)
Tuesday, July 19, 2022Azurity Pharmaceuticals Inc a private pharmaceutical company focused on developing innovative products to serve the specific needs of overlooked patients today announced the US Food and Drug Administration FDA approval of ZONISADE zonisamide oral sus...
China CDE Grants Breakthrough Therapy Designation (BTD) to Neurophth's NR082 in LHON
Saturday, July 16, 2022Neurophth Therapeutics Inc announced that the Center for Drug Evaluation CDE of China National Medical Products Administration NMPA has granted a Breakthrough Therapy Designation BTD to the Companys leading gene therapy drug candidate NR rAAVND for t...
